Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist (Q36392814)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist |
scientific article |
Statements
1 reference
Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist (English)
1 reference
Razelle Kurzrock
1 reference
Roy Herbst
1 reference
Vivek Subbiah
1 reference
Robert E Brown
1 reference
Jamie Buryanek
1 reference
Jonathan Trent
1 reference
Avi Ashkenazi
1 reference
20 August 2012
1 reference
1 reference
2541-2546
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference